SurModics, Inc.
SRDX
$27.09
$0.331.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 121.58M | 125.45M | 126.08M | 120.82M | 142.96M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 121.58M | 125.45M | 126.08M | 120.82M | 142.96M |
| Cost of Revenue | 30.79M | 31.93M | 33.03M | 23.15M | 23.09M |
| Gross Profit | 90.78M | 93.52M | 93.05M | 97.67M | 119.87M |
| SG&A Expenses | 52.93M | 53.47M | 53.14M | 55.06M | 51.31M |
| Depreciation & Amortization | 3.47M | 3.49M | 3.50M | 3.49M | 3.50M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 125.55M | 127.25M | 128.02M | 128.30M | 124.50M |
| Operating Income | -3.97M | -1.80M | -1.95M | -7.48M | 18.46M |
| Income Before Tax | -14.57M | -9.73M | -7.51M | -9.16M | 17.30M |
| Income Tax Expenses | 5.29M | 4.68M | 4.04M | -7.76M | 3.80M |
| Earnings from Continuing Operations | -19.86 | -14.41 | -11.54 | -1.40 | 13.50 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.86M | -14.41M | -11.54M | -1.40M | 13.50M |
| EBIT | -3.97M | -1.80M | -1.95M | -7.48M | 18.46M |
| EBITDA | 4.51M | 6.64M | 6.75M | 1.23M | 27.20M |
| EPS Basic | -1.40 | -1.02 | -0.81 | -0.10 | 0.96 |
| Normalized Basic EPS | -0.27 | -0.16 | -0.17 | -0.41 | 0.73 |
| EPS Diluted | -1.41 | -1.03 | -0.83 | -0.10 | 0.95 |
| Normalized Diluted EPS | -0.27 | -0.16 | -0.17 | -0.40 | 0.73 |
| Average Basic Shares Outstanding | 56.87M | 56.74M | 56.61M | 56.49M | 56.37M |
| Average Diluted Shares Outstanding | 56.87M | 56.77M | 56.64M | 56.61M | 56.51M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |